Major histocompatibility complex regulation of cytokine production

Journal of Interferon and Cytokine Research

Volumn 16, Issue 12, 1996, Pages 983-988

  Caruso, Calogero ^a,b   Candore, Giuseppina ^a   Modica, Maria Assunta ^a   Bonanno, Cesira Tiziana ^a   Sireci, Guido ^a   Dieli, Francesco ^a   Salerno, Alfredo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto di Patologia Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0030478811     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.983     Document Type: Review

References (66)

1. ALPER, C.A., AWDEH, A.Z., and YUNIS, E.J. (1992). Conserved, extended MHC haplotypes. Exp. Clin. Immunogenet. 9, 58-71.
2. ALPER, C.A. (1995). The human immune response to hepatitis B surface antigen. Exp. Clin. Immunogenet. 12, 171-181.
3. BENACERRAF, B. (1991). When all is said and done. . . Annu. Rev. Immunol. 9, 1-26.
4. NEPOM, G.T. (1989). The effects of variations in human immune-response genes. N. Engl. J. Med. 321, 751-752.
5. DAUSSET, J., and CONTU, L. (1980). The MHC and immune response in man. In: Immunology 80. Progress in Immunology IV. M. Fogerau and J. Dausset (eds.) London: Academic Press, pp. 513-529.
6. FRENCH, M.A.H., and DAWKINS, R.L. (1990). Central MHC genes, IgA deficiency and autoimmune disease. Immunol. Today 11, 271-274.
7. KRUSKALL, M.S. (1990). The major histocompatibiloity complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders. Yale J. Biol. Med. 63, 477-486.
8. BACH, J.F., and CAILLAT-ZUCMAN, S. (1993). Genetics of autoimmune endocrine diseases. Springer Semin. Immunopathol. 14, 239-249.
9. MODICA, M.A., COLUCCI, A.T., CANDORE, G., and CARUSO, C. (1993). The HLA-B8,DR3 haplotype and immune response in healthy subjects. Immunol. Infect. Dis. 3, 119-127.
10. MÖLLER, G. (ed). (1983). HLA and disease susceptibility. Immunol. Rev. 70, 1-218.
11. YEWDELL, J.W., and BENNICK, J.R. (1990). The binary logic of antigen processing and presentation to T cells. Cell 62, 203-206.
12. CLERICI, M., and SHEARER, G.M. (1994). The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15, 575-581.
13. KRENGER, W., and FERRARA, J.L.M. (1996). Graft versus host disease and the Th1/Th2 paradigm. Immunol. Res. 15, 50-73.
14. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
15. MOSMANN, T.R. (1992). T lymphocyte subsets, cytokines and effector functions. Ann. NY Acad. Sci. 664, 89-99.
16. PAUL, W.E., and SEDER, R.A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-246.
17. HASHIMOTO, S., McCOMBS, C.C., and MICHALSKI, J.P. (1993). Evidence for an ongoing role of class I histocompatibility molecules for the production of interleukin-2 in response to sub-optimal concentrations of phytohaemoagglutinin. Scand. J. Immunol. 37, 541-544.
18. XU, X., BECKMAN, I., DIMOPULOS, K., AHERN, M., and BRADLEY, J. (1992). Age-related changes in the expression of T cell activation antigens following phytohaemoagglutinin stimulation. Exp. Clin. Immunogenet. 9, 203-211.
19. ROMAGNANI, S. (1995). Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15, 121-126.
20. AMER, A., SINGH, G., DARKE, C., and DOLBY, A.E. (1986). Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3. Tissue Antigens 28, 193-198.
21. GREENBERG, L.J., and YUNIS, E.J. (1978). Histocompatibility determinants, immune responsiveness and aging in man. Fed. Proc. 37, 1258-1262.
22. MODICA, M.A., CAMMARATA, G., and CARUSO, C. (1990). HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin. J. Immunogenet. 17, 101-107.
23. CARUSO, C., CANDORE, G., CIGNA, D., COLUCCI, A.T., and MODICA, M.A. (1993). Biological significance of soluble IL-2 receptor. Mediators Inflammation 2, 3-21.
24. DURUM, S.K., SCHMIDT, J.A., and OPPENHEIM, J.D. (1985). Interleukin-1: an immunological perspective. Annu. Rev. Immunol. 3, 263-287.
25. KOIKE, M., and TAKATSU, K. (1994). IL-5 and its receptor: which role do they play in the immune response? Int. Arch. Allergy Appl. Immunol. 104, 1-9.
26. MOORE, K.W., O'GARRA, A., MALEFYT, R.DE. W., VIEIRA, P., and MOSMANN, T.R. (1993). Interleukin 10. Annu. Rev. Immunol. 11, 165-190.
27. MOLLER, G. (ed). (1987). Gamma interferon. Immunol. Rev. 97, 5-65.
28. PAUL, W.E., and OHARA, J. (1987). B-cell stimulatory factor-1/interleukin 4. Annu. Rev. Immunol. 5, 429-459.
29. VAN SNICK, J. (1990). Interleukin-6: an overview. Annu. Rev. Immunol. 8, 253-278.
30. CANDORE, G., CIGNA, D., GERVASI, F., COLUCCI, A.T., MODICA, M.A., and CARUSO, C. (1994). In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity 18, 121-132.
31. HASHIMOTO, S., McCOMBS, C.C., and MICHALSKI, J.P. (1989). Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals. Clin. Exp. Immunol. 76, 317-323.
32. MODICA, M.A., ZAMBITO, M.A., CANDORE, G., and CARUSO, C. (1990). Markers of T lymphocyte activation in HLA-B8,DR3 positive individuals. Immunobiology 181, 257-266.
33. CANDORE, G., COLUCCI, A.T., MODICA, M.A., and CARUSO, C. (1991). HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2. Immunopharmacol. Immunotoxicol. 13, 551-561.
34. MODICA, M.A., DI LORENZO, G., GALLUZZO, A., GIORDANO, C., PORTELLI, M.R., CANDORE, G., and CARUSO, C. (1990). Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8,DR3 positive subjects. Autoimmunity 7, 87-96.
35. HASHIMOTO, S., MICHALSKI, J.P., BERMAN, M.A., and McCOMBS, C. (1990). Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1. Clin. Exp. Immunol. 79, 227-232.
36. LIO, D., D'ANNA, C., GERVASI, F., CIGNA, D., MODICA, M.A., CANDORE, G., and CARUSO, C. (1995). In vitro impairment of interleukin-5 production in HLA-B8,DR3-positive individuals. Implications for immunoglobulin A synthesis dysfunction. Hum. Immunol. 44, 170-174.
37. BOHJANEN, P.R., OKAHIMA, M., and HODES, RJ. (1990). Differential regulation of interleukin-4 and interleukin-5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl. Acad. Sci. USA 87, 5283-5287.
38. MODICA, M.A., COLUCCI, A.T., CIGNA, D., CANDORE, G., and CARUSO, C. (1995). Pattern of in vitro cytokine production in HLA-B8,DR3 positive subjects. Eur. J. Immunogenet. 22 (abstract 11).
39. WILSON, A.G., DE VRIES, N., POCIOT, F., DI GIOVINE, F.S., VAN DER PUTTE, L.B.A., and DUFF, G.W. (1993). An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J. Exp. Med. 177, 557-560.
40. WILSON, A.G., GORDON, C., DI GIOVINE, F.S., DE VRIES, N., VAN DER PUTTE, L.B.A., EMERY, P., and DUFF, G.W. (1994). A genetic association between systemic lupus erythematosus and tumor necrosis factor α. Eur. J. Immunol. 24, 191-195.
41. WEAVER, C.T., and UNANUE, E.R. (1986). T cell induction of membrane IL-1 on macrophages. J. Immunol. 137, 3868-3873.
42. CANDORE, G., CIGNA, D., TODARO, M., DE MARIA, R., STASSI, G., GIORDANO, C., and CARUSO, C. (1995). T cell activation in HLA-B8,DR3 positive individuals: early antigen expression defect in vitro. Hum. Immunol. 42, 289-294.
43. TESTI, R., D'AMBROSIO, D., DE MARIA, R., and SANTONI, A. (1994). The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15, 479-481.
44. ASHERSON, G.L., DIELI, F., GAUTAM, Y., SIEW, L.K., and ZEMBALA, M. (1990). Major histocompatibility complex regulation of the class of the immune response: the H-2d haplotype determines poor interferon-γ response to several antigens. Eur. J. Immunol. 20, 1305-1311.
45. DIELI, F., SIRECI, G., BONANNO, C.T., LIO, D., and SALERNO, A. (1993). Major histocompatibility complex regulation of interleukin-5 production in the mouse. Eur. J. Immunol. 23, 2897-2902.
46. DIELI, F., and SALERNO, A. (1993). Antigen-specific production of lymphokines is influenced by the MHC/antigen complex presented to T lymphocyte. Transplant. Proc. 25, 3301-3302.
47. DIELI, F., ASHERSON, G.L., BONANNO, C.T., SIRECI, G., and SALERNO, A. (1995). Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl. Immunology 84, 355-359.
48. DIELI, F., ASHERSON, G.L., SIRECI, G., LIO, D., BONANNO, C.T., and SALERNO, A. (1995). IL-5 enhances in vitro and in vivo antigen-specific IgA production in MHC genetically determined low IL-5 responder mice. Cell. Immunol. 163, 309-313.
49. MURRAY, J.S., PFEIFFER, C., MAORI, J., and BOTTOMLY, K. (1992). Major histocompatibility complex (MHC) control of CD4 T cells subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 48, 559-564.
50. PFEIFFER, C., MURRAY, J., and MAORI, J. (1991). Selective activation of Th1- and Th2-like cells in vivo. Response to human collagen type IV A. Immunol. Rev. 123, 65-84.
51. + T cells. J. Immunol. 154, 1232-1238.
52. KOHLER, J., MARTIN, S., FLUGFELDER, U., RUH, H., VOLLMER, J., and WELTZIEN, H.A. (1995). Cross-reactive trinitrophenylated peptides as antigen for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited cell receptor repertoire. Eur. J. Immunol. 25, 92-101.
53. MATIS, L.A., GLIMCHER, L.H., and PAUL, W.E. (1983). Magnitude of response of histocompatibility-restricted T cell clones is a function of the product of the concentrations of antigens and Ie molecules. Proc. Natl. Acad. Sci. USA 80, 6019-6023.
54. - bearing T cells is stimulus-dependent. Eur. J. Immunol. 19, 231-236.
55. + T cells by conventional antigen and MLS superantigen. Proc. Natl. Acad. Sci. USA 88, 2736-2739.
56. GAJEWSKI, T.F., SCHELL, S.R., and FITCH, F.W. (1990). Evidence implicating utilization of different T-cell receptor-associated signaling pathways by Th1 and Th2 clones. J. Immunol. 144, 4110-4120.
57. + T cells in intracellular infections in humans: leishmaniasis as an example. Immunol. Today 17, 13-16.
58. HAANEN, J.B.A.G., DE WAAL MALEFIJT, R., RES, P.C.M., KRAAKMAN, E.M., OTTENHOFF, T.H.M., DE VRIES, R.R.P., and SPITS, H. (1991). Selection of a human T helper type-1 like T cell subset by mycobacteria. J. Exp. Med. 174, 583-588.
59. SURCEL, H.M., TROYE-BLOMBERG, M., PAULIE, S., ANDERSSON, G., MORENO, C., PASVOL, G., and IVANYI, J. (1994). Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81, 171-176.
60. COLUCCI, A.T., DI LORENZO, G., INGRASSIA, A., CRESCIMANNO, G., MODICA, M.A., CANDORE, G., and CARUSO, C. (1992). Blood antiphospholipid antibodies levels are influenced by age, sex, and HLA-B8,DR3 phenotype. Exp. Clin. Immunogenet. 9, 72-79.
61. JACOB, C.O., and McDEVITT, H.O. (1992). Interferon gamma and tumor necrosis factor in autoimmune disease models: implications for immunoregulation and genetic susceptibility. In: Molecular Autoimmunity. N. Talal (ed). London: Academic Press, pp. 107-126.
62. STEEL, C.M., LUDLAM, C.A., BEATSON, D., PEUTHERER, J.F., CUTHBERT, R.J.G., SIMMONDS, P., MORRISON, H., and JONES, M. (1988). HLA haplotype A1,B8,DR3 as a risk factor for HIV-related disease. Lancet 1, 1185-1188.
63. KASLOW, R.A., DUQUESNOY, R., VANRADEN, M., KINGSLEY, L., MARRAI, M., FRIEDMAN, H., SU, S., SAAH, A.J., DETELS, R., PHAIR, J., and RINALDO, C. (1990). A1,CW7,B8,DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 335, 927-930.
64. HAMMARSTROM, L., AXELSSON, U.; BJORKANDER, J., HANSON, L.A., MOLLER, E., and SMITH, C.I.E. (1984). HLA antigens in selective IgA deficiency. Tissue Antigens 24, 35-39.
65. MODICA, M.A., FREDDI, S., and CARUSO, C. (1989). Blood IgA, IgM and IgE levels are influenced by sex and HLA phenotype. Exp. Clin. Immunogenet. 6, 251-257.
66. BLUMENTHAL, M., MARCUS-BAGLEY, D., AWDEH, Z., JOHNSON, B., YUNIS, E.J., and ALPER, C.A. (1992). HLA-DR2, (HLA-B7, SC31, DR2), and (HLA-B8, SC01,DR3) haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy. J. Immunol. 148, 411-416.